Association between HOMA-IR and coexisting MASLD and type 2 diabetes: Insights from NHANES and network pharmacology.
- DOI
- 10.1177/20420188261487315
- Published
- 2026
- Container
- Therapeutic advances in endocrinology and metabolism
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/20420188261487315,
title = {Association between HOMA-IR and coexisting MASLD and type 2 diabetes: Insights from NHANES and network pharmacology.},
author = {Heng XP and Yang LQ and Chen QW and Jin LX and Li YW and Ruan Y and Han Z and Yao SH and Hong XM and Wang ZT and Li L and He WD},
year = {2026},
journal = {Therapeutic advances in endocrinology and metabolism},
doi = {10.1177/20420188261487315},
url = {https://doi.org/10.1177/20420188261487315}
}RIS
TY - JOUR TI - Association between HOMA-IR and coexisting MASLD and type 2 diabetes: Insights from NHANES and network pharmacology. AU - Heng XP AU - Yang LQ AU - Chen QW AU - Jin LX AU - Li YW AU - Ruan Y AU - Han Z AU - Yao SH AU - Hong XM AU - Wang ZT AU - Li L AU - He WD PY - 2026 JO - Therapeutic advances in endocrinology and metabolism DO - 10.1177/20420188261487315 UR - https://doi.org/10.1177/20420188261487315 ER -
APA
XP, H., LQ, Y., QW, C., LX, J., YW, L., Y, R., Z, H., SH, Y., XM, H., ZT, W., L, L., & WD, H. (2026). Association between HOMA-IR and coexisting MASLD and type 2 diabetes: Insights from NHANES and network pharmacology.. Therapeutic advances in endocrinology and metabolism. https://doi.org/10.1177/20420188261487315
Source records
- pubmed · retrieved 2026-09-25T18:14:37.959Z